This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Angioplasty and atherosclerotic renal artery stenosis

Authoring team

Renal artery stenosis is associated with hypertension in humans and laboratory animals. Patients with atherosclerotic renal artery stenosis and hypertension are commonly treated by transluminal renal artery angioplasty.

  • a systematic review investigating the management strategies for renal artery stenosis has been undertaken (1):
    • weak evidence suggested no large differences in mortality rates or cardiovascular events between medical and revascularization treatments. Acceptable evidence suggested similar kidney-related outcomes but better blood pressure outcomes with angioplasty, particularly in patients with bilateral disease. Improvements in kidney function and cure of hypertension were reported among some patients only in cohort studies of angioplasty. Evidence from direct comparisons of interventions is sparse and inadequate to draw robust conclusions
    • evidence does not clearly support one treatment approach over another for atherosclerotic renal artery stenosis

Reference:

  1. Balk E et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006 Dec 19;145(12):901-12

 


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.